CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

P3 Technology has been recognized by Life Sciences Review Magazine as the exclusive recipient of “Top Life Sciences Investment Banking Firm - 2025,” based on our proprietary methodology, reflecting its position in the industry. This profile has been developed by the Life Sciences Review research and editorial team based on insights from an interview with Heather Rose, CEO.

P3 Technology
Enhancing Healthcare Outcomes with Tailored Solutions

P3 Technology

Heather Rose, P3 Technology | Life Science Review | Top Life Sciences Investment Banking FirmHeather Rose, CEO
Until you have walked a mile in someone’s shoes, solving their problems remains an abstract concept – this philosophy is the backbone of P3 Technology.

The company collected comprehensive data regarding the specific challenges manufacturer’s (Pharma, Biotech, Digital Therapeutics) face in running Patient Support Programs, using it to design a case management system (CMS) to improve coordination and management throughout a patient’s treatment journey. The primary aim of this system is to enhance the user experience by ensuring seamless coordination through tailored workflows, which in turn not only amplifies data quality but also unlocks sophisticated business insights. This deliberate design fosters better outcomes for patients and elevates the respective brands.

The platform’s capabilities derive from the experience of P3 Technology’s CEO, Heather Rose, who has worked many years in the patient services operations space. The design is also informed by the technological knowledge of CTO David Galownia, who has over two decades of experience developing custom software solutions. Their collective expertise, encapsulated in the CMS platform, provides Customers a seamless path to tackling the innate complexities in patient services.

“Designed by patient services experts, our platform offers a user-friendly interface with configurable workflows, boosting efficiency and productivity. It adapts to evolving needs, streamlining operations directly for the user without intermediary technology,” says Rose.

The CMS is distinguished by its comprehensive feature set that spans workflow management, data entry systems, and automation capabilities. Clients can configure these elements to their needs, even marking certain fields as mandatory or optional. This flexibility extends to integrating standard case management phases, like enrollment and benefit verification, while allowing for adjustments tailored to each client’s requirements.

In addition to its configurability, the platform excels at automating patient adherence processes. This includes creating tasks and follow-ups, enabling outbound SMS, email, and fax communication, and facilitating seamless, third-party fulfillment integration. With robust security commitment and integration flexibility, the platform emerges as a versatile and reliable solution for its clients in the Life Sciences industry.

“Cloud-hosted in AWS, the CMS’s installation is entirely private to your organization, with best practices followed to meet HIPAA requirements,” says Galownia.

Designed by patient services experts, our platform offers a user-friendly interface with configurable workflows, boosting efficiency and productivity. It adapts to evolving needs, streamlining operations directly for the user without intermediary technology


A case in point is P3’s ongoing partnership with a firm focused on a rare disease product. The previous system used by the client made their complex processes even more cumbersome. P3 offered a solution that streamlined operations and improved data quality through task driven workflows. This ease of use is essential in reducing processing time and getting new hires up to speed.

The system’s capabilities extend beyond operational efficiency. Data analytics and insight form another cornerstone of the platform. P3 incorporates Amazon QuickSight, allowing for actionable insights in various charts and graphs. This analytical power caters to organizational roles, from operational staff to executive leadership.

P3 places high value on customer feedback. Regular usability audits involve frontline agents ensuring that even the smallest user interface details meet practical needs. This open channel for feedback fosters constant improvement and aligns perfectly with the company’s goal to create software users enjoy. Clients appreciate the platform’s capabilities, the approachable team behind it, and the overall affordability of the solution.

As Rose notes, their ultimate goal is to allow Patient Services teams to focus their energies on what matters most – caring for patients. Achieving this involves a dedication to creating a tool that fits seamlessly into day-to-day operations, backed by a team that understands the obscurities of technology and patient services.

P3 distinguishes itself through its dual focus on operational efficiency and user experience in a competitive landscape. CMS’ customizability and analytical features set it apart as a comprehensive solution, adaptable to the convolutions of patient services. With satisfied customers and a promise of continual improvement, P3 is walking more than a mile in its users’ shoes; it is blazing a trail.

Top Life Sciences Investment Banking Firm - 2025
Current Issue

Company : P3 Technology

Management
Heather Rose, CEO

Thank you for Subscribing to Life Science Review Weekly Brief

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/p3-technology